What is ColdBlock Technologies?
Founded in 2014, ColdBlock Technologies is a Canadian-based enterprise that has developed a proprietary sample digestion technology known as ColdBlock Digestion. This innovation addresses critical bottlenecks in laboratory workflows by providing a faster, more efficient, and safer method for preparing samples for analysis. The company serves a wide array of industries, including environmental monitoring, metals and alloys, mining, food and agriculture, and pharmaceuticals. By replacing conventional, time-consuming digestion techniques with its high-performance hardware, ColdBlock enables laboratories to increase throughput while maintaining rigorous quality standards. The company's market position is defined by its commitment to modernizing the laboratory environment through advanced engineering and process optimization.
How much funding has ColdBlock Technologies raised?
ColdBlock Technologies has raised a total of $1.5M across 1 funding round:
Series A
$1.5M
Series A (2020): $1.5M with participation from Angel One, Georgian Angel Network, Peterborough Region Angel Network, York Angel Investors, and Niagara Angel Network
Key Investors in ColdBlock Technologies
Georgian Angel Network
Georgian Angel Network connects angel investors with entrepreneurs to facilitate the commercialization of innovative ideas, acting as a catalyst for economic development.
York Angel Investors
York Angel Investors is a leading Canadian network that utilizes an AI-powered platform to streamline startup discovery and due diligence for high-growth opportunities.
Angel One
Angel One is a prominent investment group focused on supporting early-stage ventures through capital and strategic mentorship.
What's next for ColdBlock Technologies?
With the recent capital injection, ColdBlock Technologies is expected to focus on scaling its manufacturing capabilities and expanding its commercial footprint into international markets. The strategic roadmap likely involves deepening its penetration within the mining and pharmaceutical sectors, where the demand for high-throughput, accurate sample preparation is consistently rising. Furthermore, the company is well-positioned to leverage its current momentum to enhance its product suite, potentially integrating more automated features to align with the industry-wide shift toward smart, digitized laboratory workflows. As the company matures, the focus will likely shift toward establishing long-term partnerships with global analytical service providers, ensuring that ColdBlock Digestion becomes the industry standard for modern sample preparation.
See full ColdBlock Technologies company page
